Silverarc Capital Management, LLC Gamida Cell Ltd. Transaction History

Silverarc Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.85 - $8.33 $136,849 - $194,863	-23,393 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$7.8 - $12.43 $370,180 - $589,915	-47,459 Reduced 66.98%	23,393 $189,000
Q4 2020 Feb 16, 2021	BUY	$4.07 - $11.0 $288,367 - $779,372	70,852 New	70,852 $594,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.